Trials / Completed
CompletedNCT00935064
The Effect of Renin Inhibition on Nerve Function in Diabetes
Effect of Renin Inhibition on Cardiovascular Autonomic Nerve Function in Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Christiana Care Health Services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the effect of direct renin inhibition on nerve function in persons with diabetes using a double-blind, placebo-controlled randomized trial involving two treatment arms (i.e., \[1\] 30 participants enrolled and randomized to 300 mg of Aliskiren; \[2\] 30 participants enrolled and randomized to placebo).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aliskiren | Pill, 300 mg, once daily, for 6 weeks |
| OTHER | Placebo | Placebo orally one tablet once a day for 6 weeks. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-10-01
- Completion
- 2012-04-01
- First posted
- 2009-07-08
- Last updated
- 2016-08-09
- Results posted
- 2013-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00935064. Inclusion in this directory is not an endorsement.